Diseases, Conditions, Syndromes

Hunting Ebola's origins

The outbreak of Ebola that started in 2013 in West Africa, infecting nearly 30,000 people and killing 11,000 before it ended in 2016, has long left scientists puzzling over a key question: Where did the virus originate?

Oncology & Cancer

Scientists design protein that prods cancer-fighting T-cells

Scientists at UW Medicine's Institute for Protein Design (IPD) in Seattle have created a new protein that mimics the action of a key immune regulatory protein, interleukin 2 (IL-2).  IL-2 is a potent anticancer drug and ...

Diseases, Conditions, Syndromes

Contact with monkeys and apes puts populations at risk

Animal diseases that infect humans are a major threat to human health, and diseases often spillover to humans from nonhuman primates. Now, researchers reporting in PLOS Neglected Tropical Diseases have carried out an extensive ...

Parkinson's & Movement disorders

A toxin that travels from stomach to brain may trigger Parkinsonism

Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism—symptoms typical of Parkinson's disease like body tremors and slowing of body motions—after the toxin travels ...

Diseases, Conditions, Syndromes

Modified malaria drug proven effective at inhibiting Ebola

Robert Davey, professor of microbiology at Boston University School of Medicine and researcher at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), in collaboration with researchers at Nagasaki ...

page 33 from 40